Media & Press Releases

ISPE and the University of St.Gallen, Switzerland, announced today that they had signed a Memorandum of Understanding (MOU) to collaborate on tools designed to advance the state of pharmaceutical quality. ISPE’s Advancing Pharmaceutical Quality (APQ)...

ISPE announced today the formation of the new Eurasian Economic Union (Eurasia) Affiliate. The Affiliate will provide a local forum through which professionals in Russia, Armenia, Belarus, Kazakhstan, and Kyrgyzstan can contribute to the advancement...

ISPE announced that Thomas B. Hartman has been appointed as CEO & President, effective 1 June 2020. Tom has a long history of success in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, for...

ISPE announced featured presenters representing the Food and Drug Administration (FDA) at the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference. Taking place 1–2 June 2020, this first of its kind fully interactive digital event features...

ISPE announced today the 2020 Facility of the Year Awards (FOYA) Category Winners—including two winners of the inaugural Social Impact Category Award. Awardees include: F. Hoffmann-La Roche Ltd ( Equipment Innovation) Pfizer, Inc. ( Facility...

ISPE announced today that it has named Jean-François Duliere as a European Regulatory Advisor. Effective 1 April 2020, Duliere takes on this role at ISPE with extensive experience in pharmaceutical regulatory compliance and facilities design for...

ISPE announced Wilson Bryan, MD, Director, Office of Tissues and Advanced Therapies, FDA, as a newly confirmed keynote for the 2020 ISPE Biopharmaceutical Manufacturing Conference, taking place 1–3 June 2020 in Boston, Massachusetts. Wilson Bryan is...

Update 10 April 2020: The search for the new ISPE President and CEO has resumed. At this time, the candidate submission period has closed. The ISPE President and CEO is responsible for providing strategic leadership for the organization by working...

Updated 29 May, 2020 ISPE is closely monitoring the evolution of the Coronavirus situation and we are following the World Health Organization (WHO) guidance and travel advice. Every precaution is being taken to ensure the health and safety of our...

ISPE announced its keynote presenters for the 2020 ISPE Europe Annual Conference. Taking place on 30 March–1 April 2020 in Madrid, Spain, keynote addresses showcase senior-level global pharmaceutical industry leaders offering compelling and...